Company profile
Vireo Growth Inc. CIK 1771706
Ticker
VREOF (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Minneapolis, MN 55402
Fiscal year end
2025 (FY)
Key Financials
Revenue
$268.77M
Net income
-$68.11M
Total assets
$817.15M
Total liabilities
$509.73M
Stockholders' equity
$307.42M
Cash & equivalents
$122.49M
Operating income
-$1.05M
Operating cash flow
$3.71M
Capital expenditures
$28.32M
Fiscal year 2025, via 10-K filed 2026-03-17. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-0.4%
Net margin
-25.3%
Free cash flow
-$24.61M
Free cash flow margin
-9.2%
Liabilities / assets
62.4%
Equity / assets
37.6%
CapEx / revenue
10.5%
Operating cash flow / net income
-0.05×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$268.77M
-$68.11M
$817.15M
$509.73M
$307.42M
2024
$99.38M
-$28.01M
$278.86M
$223.30M
$55.56M
2023
$88.13M
-$25.55M
$183.26M
$199.31M
-$16.04M
2022
$74.63M
-$42.46M
$159.16M
$155.72M
$3.44M
2021
$54.45M
-$33.69M
$166.97M
$123.96M
$43.01M
Company Details
SIC code
2834
State of incorporation
A1
Active filer
Yes
Most recent SEC filing
Form 425
2026-08-28
Financials filed via
Form 10-K
filed 2026-03-17
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Minneapolis, MN 55402
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:36 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.